Prior oral antithrombotic therapy is associated with early death in patients with supratentorial intracerebral hemorrhage

Internal Medicine

Volumn 50, Issue 5, 2011, Pages 413-419

  Yamashita, Shinji ^a   Kimura, Kazumi ^a   Iguchi, Yasuyuki ^a   Shibazaki, Kensaku ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Early death; Oral antithrombotic therapy; Supratentorial intracerebral hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; GLUCOSE; TICLOPIDINE; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEATH; FEMALE; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; WARFARIN;

EID: 79952335473     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4239     Document Type: Article

References (30)

1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 344: 1450-1460, 2001.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995.
3. Mayer SA, Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol 4: 662-672, 2005.
4. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36: 1588-1593, 2005.
5. Ogawa H, Nakayama M, Morimoto T, et al; Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 300: 2134-2141, 2008.
6. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 93: 606-612, 2007.
7. Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 65: 1000-1004, 2005.
8. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63: 1059-1064, 2004.
9. Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I. Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 55: 1121-1124, 1992.
10. Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P; CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 39: 2993-2996, 2008.
11. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32: 891-897, 2001.
12. Toyoda K, Okada Y, Ibayashi S, et al. Antithrombotic therapy and predilection for cerebellar hemorrhage. Cerebrovasc Dis 27: 109-116, 2007.
13. Roquer J, Rodríguez Campello A, Gomis M, Ois A, Puente V, Munteis E. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol 252: 412-416, 2005.
14. van Swieten JC, Koudstaal PJ, Visser MC, Schouten H, Jvan Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604-607, 1988.
15. Toyoda K, Yasaka M, Nagata K, et al; Bleeding with Antithrombotic Therapy (BAT) Study Group. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study. Cerebrovasc Dis 27: 151-159, 2009.
16. Toyoda K, Yasaka M, Iwade K, et al; Bleeding with Antithrombotic Therapy (BAT) Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke 39: 1740-1745, 2008.
17. Kimura K, Kazui S, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigators Collaboration. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc Dis 18: 47-56, 2004.
18. Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 29: S1-S105, 2006.
19. Kuzuya T, Nakagawa S, Satoh J, et al; Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetes Res Clin Pract 55: 65-85, 2002.
20. Miyahara K, Murata H, Abe H. Predictors of intracranial hematoma enlargement in patients undergoing hemodialysis. Neurol Med Chir (Tokyo) 47: 47-51, 2007.
21. Grønbaek H, Johnsen SP, Jepsen P, et al. Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study. BMC Gastroenterology 8: 16, 2008.
22. Kothari RU, Brott T, Brodrick JP, Barsan WG, Sauerbeck LR, Zuccarello M. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27: 1304-1305, 1996.
23. Caso V, Paciaroni M, Venti M, et al. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage. Cerebrovasc Dis 24: 215-218, 2007.
24. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30: 905-915, 1999.
25. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke; a Journal of Cerebral Circulation 38: 2001-2023, 2007.
26. Kimura K, Iguchi Y, Inoue T, et al. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci 255: 90-94, 2007.
27. Itabashi R, Yasaka M, Kuwashiro T, et al. Location of acute brain hemorrhage in patients undergoing antithrombotic therapy. J Neurol Sci 280: 87-89, 2009.
28. Neau JP, Couderq C, Ingrand P, Blanchon P, Gil R; VGP Study Group. Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 11: 195-200, 2001.
29. Nicolini A, Ghirarduzzi A, Iorio A, Silingardi M, Malferrari G, Baldi G. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 87: 948-956, 2002.
30. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 36: 1801-1807, 2005.